Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
β-thalassemia is characterised by the presence of an excess of α-globin chains, which contribute to erythrocyte pathology. Here the authors use CRISP/Cas9 to reduce α-globin expression in hematopoietic precursors, and show effectiveness in xenograft assays in mice.
Guardado en:
Autores principales: | Sachith Mettananda, Chris A. Fisher, Deborah Hay, Mohsin Badat, Lynn Quek, Kevin Clark, Philip Hublitz, Damien Downes, Jon Kerry, Matthew Gosden, Jelena Telenius, Jackie A. Sloane-Stanley, Paula Faustino, Andreia Coelho, Jessica Doondeea, Batchimeg Usukhbayar, Paul Sopp, Jacqueline A. Sharpe, Jim R. Hughes, Paresh Vyas, Richard J. Gibbons, Douglas R. Higgs |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0cd23b9b09ec4af18f7d483a67ceba18 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reciprocal regulation of γ-globin expression by exo-miRNAs: Relevance to γ-globin silencing in β-thalassemia major
por: Kuo-Ting Sun, et al.
Publicado: (2017) -
Molecular Analysis of β-Globin Mutations Among β-Thalassemia Patients in Hamadan
por: Fatemeh Ramezani, et al.
Publicado: (2021) -
Reactivation of a developmentally silenced embryonic globin gene
por: Andrew J. King, et al.
Publicado: (2021) -
A revised model for promoter competition based on multi-way chromatin interactions at the α-globin locus
por: A. Marieke Oudelaar, et al.
Publicado: (2019) -
A phylogenetic analysis of the globins in fungi.
por: David Hoogewijs, et al.
Publicado: (2012)